182 related articles for article (PubMed ID: 14724588)
21. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
[TBL] [Abstract][Full Text] [Related]
22. Protection of rat hepatocytes from apoptosis by inhibition of c-Jun N-terminal kinase.
Marderstein EL; Bucher B; Guo Z; Feng X; Reid K; Geller DA
Surgery; 2003 Aug; 134(2):280-4. PubMed ID: 12947330
[TBL] [Abstract][Full Text] [Related]
23. The prosurvival activity of p53 protects cells from UV-induced apoptosis by inhibiting c-Jun NH2-terminal kinase activity and mitochondrial death signaling.
Lo PK; Huang SZ; Chen HC; Wang FF
Cancer Res; 2004 Dec; 64(23):8736-45. PubMed ID: 15574785
[TBL] [Abstract][Full Text] [Related]
24. c-Jun N-terminal kinase mediates microtubule-depolymerizing agent-induced microtubule depolymerization and G2/M arrest in MCF-7 breast cancer cells.
Chen J; Sun WL; Wasylyk B; Wang YP; Zheng H
Anticancer Drugs; 2012 Jan; 23(1):98-107. PubMed ID: 21968419
[TBL] [Abstract][Full Text] [Related]
25. Synergetic and Antagonistic Molecular Effects Mediated by the Feedback Loop of p53 and JNK between Saikosaponin D and SP600125 on Lung Cancer A549 Cells.
Chen X; Liu C; Zhao R; Zhao P; Wu J; Zhou N; Ying M
Mol Pharm; 2018 Nov; 15(11):4974-4984. PubMed ID: 30207732
[TBL] [Abstract][Full Text] [Related]
26. The JNK, ERK and p53 pathways play distinct roles in apoptosis mediated by the antitumor agents vinblastine, doxorubicin, and etoposide.
Brantley-Finley C; Lyle CS; Du L; Goodwin ME; Hall T; Szwedo D; Kaushal GP; Chambers TC
Biochem Pharmacol; 2003 Aug; 66(3):459-69. PubMed ID: 12907245
[TBL] [Abstract][Full Text] [Related]
27. Quantitative effects on c-Jun N-terminal protein kinase signaling determine synergistic interaction of cisplatin and 17-allylamino-17-demethoxygeldanamycin in colon cancer cell lines.
Vasilevskaya IA; Rakitina TV; O'Dwyer PJ
Mol Pharmacol; 2004 Jan; 65(1):235-43. PubMed ID: 14722256
[TBL] [Abstract][Full Text] [Related]
28. Roles of JNK, p38 and ERK mitogen-activated protein kinases in the growth inhibition and apoptosis induced by cadmium.
Chuang SM; Wang IC; Yang JL
Carcinogenesis; 2000 Jul; 21(7):1423-32. PubMed ID: 10874022
[TBL] [Abstract][Full Text] [Related]
29. Apoptosis resistance of MCF-7 breast carcinoma cells to ionizing radiation is independent of p53 and cell cycle control but caused by the lack of caspase-3 and a caffeine-inhibitable event.
Essmann F; Engels IH; Totzke G; Schulze-Osthoff K; Jänicke RU
Cancer Res; 2004 Oct; 64(19):7065-72. PubMed ID: 15466201
[TBL] [Abstract][Full Text] [Related]
30. Conflicting evidence for the role of JNK as a target in breast cancer cell proliferation: Comparisons between pharmacological inhibition and selective shRNA knockdown approaches.
Wood RA; Barbour MJ; Gould GW; Cunningham MR; Plevin RJ
Pharmacol Res Perspect; 2018 Feb; 6(1):. PubMed ID: 29417765
[TBL] [Abstract][Full Text] [Related]
31. Taxol-induced growth arrest and apoptosis is associated with the upregulation of the Cdk inhibitor, p21WAF1/CIP1, in human breast cancer cells.
Choi YH; Yoo YH
Oncol Rep; 2012 Dec; 28(6):2163-9. PubMed ID: 23023313
[TBL] [Abstract][Full Text] [Related]
32. C-Jun NH(2)-terminal kinase mediates proliferation and tumor growth of human prostate carcinoma.
Yang YM; Bost F; Charbono W; Dean N; McKay R; Rhim JS; Depatie C; Mercola D
Clin Cancer Res; 2003 Jan; 9(1):391-401. PubMed ID: 12538493
[TBL] [Abstract][Full Text] [Related]
33. Involvement of c-Jun N-terminal kinase in G2/M arrest and FasL-mediated apoptosis induced by a novel indoloquinoline derivative, IQDMA, in K562 cells.
Yang SH; Chien CM; Lu CM; Chen YL; Chang LS; Lin SR
Leuk Res; 2007 Oct; 31(10):1413-20. PubMed ID: 17397922
[TBL] [Abstract][Full Text] [Related]
34. Cordycepin causes p21WAF1-mediated G2/M cell-cycle arrest by regulating c-Jun N-terminal kinase activation in human bladder cancer cells.
Lee SJ; Kim SK; Choi WS; Kim WJ; Moon SK
Arch Biochem Biophys; 2009 Oct; 490(2):103-9. PubMed ID: 19733546
[TBL] [Abstract][Full Text] [Related]
35. Involvement of reactive oxygen species/c-Jun NH(2)-terminal kinase pathway in kotomolide A induces apoptosis in human breast cancer cells.
Kuo PL; Chen CY; Tzeng TF; Lin CC; Hsu YL
Toxicol Appl Pharmacol; 2008 Jun; 229(2):215-26. PubMed ID: 18374381
[TBL] [Abstract][Full Text] [Related]
36. Biologic sequelae of c-Jun NH(2)-terminal kinase (JNK) activation in multiple myeloma cell lines.
Hideshima T; Hayashi T; Chauhan D; Akiyama M; Richardson P; Anderson K
Oncogene; 2003 Nov; 22(54):8797-801. PubMed ID: 14647474
[TBL] [Abstract][Full Text] [Related]
37. Oridonin induces G2/M arrest and apoptosis via activating ERK-p53 apoptotic pathway and inhibiting PTK-Ras-Raf-JNK survival pathway in murine fibrosarcoma L929 cells.
Cheng Y; Qiu F; Ye YC; Tashiro S; Onodera S; Ikejima T
Arch Biochem Biophys; 2009 Oct; 490(1):70-5. PubMed ID: 19699177
[TBL] [Abstract][Full Text] [Related]
38. c-Jun N-terminal kinase is essential for growth of human T98G glioblastoma cells.
Potapova O; Gorospe M; Bost F; Dean NM; Gaarde WA; Mercola D; Holbrook NJ
J Biol Chem; 2000 Aug; 275(32):24767-75. PubMed ID: 10825181
[TBL] [Abstract][Full Text] [Related]
39. JNK pathway regulates estradiol-induced apoptosis in hormone-dependent human breast cancer cells.
Altiok N; Koyuturk M; Altiok S
Breast Cancer Res Treat; 2007 Nov; 105(3):247-54. PubMed ID: 17187235
[TBL] [Abstract][Full Text] [Related]
40. Growth factors and chemotherapeutic modulation of breast cancer cells.
Ciftci K; Su J; Trovitch PB
J Pharm Pharmacol; 2003 Aug; 55(8):1135-41. PubMed ID: 12956904
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
